Krka Ranks in Top 10% of Pharmaceutical Industry in 2024 S&P Global Corporate Sustainability Assessment

Krka Ranks in Top 10% of Pharmaceutical Industry in 2024 S&P Global Corporate Sustainability Assessment

(IN BRIEF) Krka achieved a score of 56 out of 100 in the 2024 S&P Global Corporate Sustainability Assessment, ranking the company among the top 10% of pharmaceutical firms. This marks an improvement over the previous year’s performance and highlights Krka’s commitment to sustainability and responsible governance. The company focuses on patient well-being by providing high-quality medicines and places a strong emphasis on environmental protection and ethical business practices. This improved score serves as both an acknowledgment of their progress and a commitment to further enhancing their sustainability efforts.

(PRESS RELEASE) NOVO MESTO, 3-Feb-2025 — /EuropaWire/ — On January 31, 2025, Krka received a score of 56 out of 100 in the 2024 S&P Global Corporate Sustainability Assessment, placing the company within the top 10% of pharmaceutical industry players. This marks a notable improvement from the previous year’s assessment, highlighting Krka’s ongoing commitment to sustainable practices and responsible governance.

The score reflects Krka’s dedication to its environmental, social, and governance (ESG) principles. The company prioritizes its social responsibility and the health and well-being of patients by ensuring access to high-quality, safe, and effective medicines produced in line with the highest manufacturing standards. Alongside patient care, Krka places a strong focus on minimizing its environmental impact through proactive environmental protection measures. Additionally, the company upholds the highest standards of business ethics, transparency, and integrity in its governance.

The improved score is not only a recognition of Krka’s current efforts but also serves as a motivating factor to continue enhancing its sustainability practices moving forward.

Media Contact:

Phone: (+386) 7 331 21 11
Fax: (+386) 7 332 15 37
Email: info@krka.biz

SOURCE: KrKa

Follow EuropaWire on Google News
EDITOR'S PICK:

Comments are closed.